From data to wisdom: harnessing the power of multimodal approach for personalized atherosclerotic cardiovascular risk assessment
- PMID: 38264704
- PMCID: PMC10802815
- DOI: 10.1093/ehjdh/ztad068
From data to wisdom: harnessing the power of multimodal approach for personalized atherosclerotic cardiovascular risk assessment
Conflict of interest statement
Conflict of interest: K.N.: Advisory board of Nova Nordisk, Novartis, Esperion. Speaker Bureau Amgen. The research is partly supported by grants from NIH, Novartis, Esperion, and Jerold B. Katz Academy of Translational Research. S.A.-K. has no disclosures.
Figures
Comment in
References
-
- Nasir K, DeFilippis A. Big data and ASCVD risk prediction: building a better mouse trap? J Am Coll Cardiol 2022;79:1167–1169. - PubMed
Publication types
LinkOut - more resources
Full Text Sources